Mount Sinai Health System Experts at the 2015 ARVO Research Meeting
With more than 50 presentations, New York Eye and Ear Infirmary of Mount Sinai and Mount Sinai Health System faculty are leading scientific contributors at the upcoming annual meeting of the Association of Research and Vision in Ophthalmology (ARVO), May 3 – 7, 2015 in Denver, CO.
ARVO is the world’s largest and most respected eye and vision research organizations. Each spring, the annual meeting draws approximately 10,000 scientists and physicians who present their latest research results to peers.
Presentations from Mount Sinai researchers at the Icahn School of Medicine include new revelations into how macular degeneration impacts patients with AIDS, the increasing resistance of ocular pathogens to conventional antibiotic treatments, the ability to track diabetes progression through the eyes, identification of novel biomarkers for primary open angle glaucoma, and the risk of corneal abrasions during lengthy surgical procedures.
Key abstract presentations from the Mount Sinai Health System include:
Sunday, May 3:
Embargoed: 8:30 am
Antibiotic Resistance Among Ocular Pathogens – Results from the ARMOR Surveillance Study 2013-Present
- Penny Asbell, MD, Professor of Ophthalmology and Director of the Cornea Service and Refractive Surgery Center, The Mount Sinai Hospital
Monday, May 4:
Embargoed: 8:30 am
Prevalence of Intermediate-Stage Age-Related Macular Degeneration in Patients with the Acquired Immunodeficiency Syndrome
Douglas Jabs, MD, Professor of Ophthalmology and Medicine and Chairman Emeritus of the Department of Ophthalmology, Icahn School of Medicine at Mount Sinai
Embargoed: 12:00 pm
Impaired Lysosomal and Mitochondrial Function in Exfoliation Glaucoma
Audrey Bernstein, PhD, Assistant Professor of Ophthalmology and Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai
Robert Ritch, MD, Shelley and Steven Einhorn Distinguished Chair, and Surgeon Director and Chief, Glaucoma Services, New York Eye and Ear Infirmary of Mount Sinai
Embargoed: 4:25 pm
Changes Over Time in Retinal Vessels in Patients with Early Diabetes
Richard Rosen, MD, Professor of Ophthalmology, Vice Chair and Director of Ophthalmology Research, New York Eye and Ear Infirmary of Mount Sinai
Tuesday, May 5:
Embargoed: 8:30 am
Corneal Abrasion Following Anesthesia for Non-Ocular Surgical Procedures: A Case-Control Study
Priti Batta, MD, Assistant Professor of Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai
Ronald C. Gentile, MD, Professor of Ophthalmology and Director of the Ocular Trauma Service, New York Eye and Ear Infirmary of Mount Sinai
Embargoed: 3:45 pm
Developing Micro-RNAs as Biomarkers for Primary Open Angle Glaucoma
Robert Ritch, MD, Shelley and Steven Einhorn Distinguished Chair, and Surgeon Director and Chief, Glaucoma Services, New York Eye and Ear Infirmary of Mount Sinai
About New York Eye and Ear Infirmary of Mount Sinai
New York Eye and Ear Infirmary of Mount Sinai (NYEE) is one of the world's leading facilities for the diagnosis and treatment of all diseases of the eyes, ears, nose, and throat, as well as related conditions. Founded in 1820 as the nation's first specialty hospital, NYEE manages more than 30,000 surgical cases and 225,000 outpatient visits per year. NYEE is regularly ranked as one of the best hospitals in America for Ophthalmology, according to U.S. News & World Report, and has been awarded Magnet status twice for excellence in nursing care.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in several pediatric specialties.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.